Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
Narrative Expertise in Oncology: An Integrated Training Model to Advance the Field
Trisha K Paul1,2, Erica C Kaye3
1Department of Pediatrics, Division of Hematology/Oncology, University of Rochester Medical Center, 601 Elmwood Ave, Box 777, Rochester, NY, 14642, United States, 1 585-275-2981.
Integrating a Master of Fine Arts (MFA) with hematology-oncology fellowship training can enhance narrative competence. This approach supports clinician well-being, resilience, and advances humanism in cancer care, research, and advocacy.
Area of Science:
- Medical Humanities
- Hematology-Oncology
- Medical Education
Background:
- Growing evidence supports narrative expertise's benefits in cancer care.
- Few hematology-oncology trainees pursue humanities graduate degrees.
- Humanism in medicine is crucial for healthcare professionals.
Purpose of the Study:
- Advocate for integrating a Master of Fine Arts (MFA) degree with fellowship training.
- Promote narrative competence among hematology-oncology trainees.
- Enhance humanism in hematology-oncology practice, education, research, and advocacy.
Main Methods:
- Review of evidence on narrative competence and clinician well-being.
- Proposal of a concurrent MFA and fellowship training pathway.
- Discussion of the role of narrative competence in mitigating moral distress and enhancing resilience.
Main Results:
- Narrative competence improves clinician well-being, resilience, and mitigates moral distress.
- MFA training equips trainees with advanced narrative skills.
- Narrative competence positively impacts patient care, research, education, and advocacy.
Conclusions:
- Integrating MFA programs into hematology-oncology fellowships is a strategic investment.
- This pathway cultivates thought leaders in narrative competence.
- It fosters the next generation of hematologist-oncologists skilled in humanism and narrative expertise.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Interdisciplinary Care: The Health Care Team-I
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
Tumor Immunotherapy

